Literature DB >> 7406535

[Ehlers-Danolos syndrome: a disease of fibroblasts and collagen fibrils. Classification and electron-microscopic findings in five patients (author's transl)].

M Sevenich, U Schultz-Ehrenburg, C E Orfanos.   

Abstract

Five patients with Ehlers-Danlos syndrome (EDS) were classified according to clinical and genetic criteria and were examined by electron microscopy: two cases in Type I and one case each in Types II, III, and V were found. In all cases distinct ultrastructural changes were seen in the fibroblasts and the collagen fibrils whereas the elastic fibers were normal, as shown with special staining techniques. a) The fibroblasts were smaller, their cytoplasmic processes reduced in number and size, the endoplasmic reticulum was underdeveloped and their ribosome content was diminished. Also, cellular degeneration up to necrosis was found. In three cases intercellular substances were seen, possibly indicating a prefibrillar secretion product of the fibroblasts. b) The collagen fibrils revealed a defective lateral aggregation with disturbances of their thickness growth. Characteristic are abnormal fibrils with star-shaped cross profiles and marginal serrations in longitudinal sections. Their periodicity, however, remained normal. In three cases (Types I, I, and V) scattered giant fibrils were also present. Generally, the bundling of collagen fibrils into fibers seemed to be loosened. These findings were common to all various types of EDS. Therefore, a classification was not possible according to criteria of electron microscopy. Ehlers-Danlos syndrome is a disease of fibroblasts leading to changes of dermal collagen.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7406535     DOI: 10.1007/bf00403845

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  25 in total

Review 1.  [Collagen diseases].

Authors:  W N Meigel; P K Müller
Journal:  Med Klin       Date:  1975-08-01

2.  EHLERS-DANLOS SYNDROME. PATHOLOGIC, HISTOCHEMICAL AND ELECTRON MICROSCOPIC OBSERVATIONS.

Authors:  H L WECHSLER; E R FISHER
Journal:  Arch Pathol       Date:  1964-06

3.  Connective tissue metabolism in culture fibroblasts of a patient with Ehlers-Danlos syndrome type I.

Authors:  H Shinkai; O Hirabayashi; A Tamaki; S Matsubayashi; S Sano
Journal:  Arch Dermatol Res       Date:  1976-12-15       Impact factor: 3.017

4.  Ehlers-Danlos syndrome; a clinical and genetic study.

Authors:  S A M JOHNSON; H F FALLS
Journal:  Arch Derm Syphilol       Date:  1949-07

Review 5.  Biosynthesis of collagen and its alterations in pathological states.

Authors:  K I Kivirikko; L Risteli
Journal:  Med Biol       Date:  1976-06

6.  Lysyl oxidase deficiency in Ehlers-Danlos syndrome type V.

Authors:  N Di Ferrante; R D Leachman; P Angelini; P V Donnelly; G Francis; A Almazan
Journal:  Connect Tissue Res       Date:  1975       Impact factor: 3.417

7.  Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome.

Authors:  A Vogel; K A Holbrook; B Steinmann; R Gitzelmann; P H Byers
Journal:  Lab Invest       Date:  1979-02       Impact factor: 5.662

8.  Editorial: Multiple forms of the Ehlers-Danlos syndrome.

Authors:  V A McKusick
Journal:  Arch Surg       Date:  1974-10

9.  [Maturation and aging of elastic fibers (authors transl)].

Authors:  R Stadler; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1978-06-29       Impact factor: 3.017

10.  Patients with Ehlers-Danlos syndrome type IV lack type III collagen.

Authors:  F M Pope; G R Martin; J R Lichtenstein; R Penttinen; B Gerson; D W Rowe; V A McKusick
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

View more
  2 in total

1.  Alterations of collagen in lichen amyloidosus.

Authors:  D Tsambaos; R Bolling
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

Review 2.  Genetics of eosinophilic esophagitis.

Authors:  L C Kottyan; M E Rothenberg
Journal:  Mucosal Immunol       Date:  2017-02-22       Impact factor: 7.313

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.